Participate in Research

The CONFORM Pivotal Clinical Trial for People with AFib
Protocol: STUDY00006904
Full Title
The CONFORM Pivotal Trial: An Evaluation of the Safety and Effectiveness of the Conformal CLAAS System for Left Atrial Appendag
The University at Buffalo (UB) Department of Medicine is enrolling adults with atrial fibrillation (or “AFib”) that are worried about their risk of having a stroke. People with AFib have a heart condition that causes the upper chambers of their hearts to beat irregularly, or differently than they should. The goal of the study is to see if a new study device (the CLAAS System) can reduce the risk of stroke without the need for blood thinners.

Participants will be enrolled in this study for 5 years. Before the surgery, the study doctor will conduct a physical exam, lab tests, imaging tests, and surveys. Following the surgery to implant the study device, they will attend follow-up visits at 7 days, 45 days, 6 months, 12 month, 18 months, 2 years, 3 years, 4 years, and 5 years for physical exams, lab tests, imaging test, and surveys.
Compensation: No
Adults 18 years or older Have been diagnosed with atrial fibrillation (or AFib) Are at risk for stroke
Age Group: Adults
Principal Investigator: VIJAY IYER Open Study
+1 716-829-6115
+1 716-888-4881
Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions